ADH

INTEGRAL AD SCIENCE EARNS MRC ACCREDITATION FOR INTEGRATED THIRD PARTY CALCULATION AND REPORTING OF YOUTUBE VIDEO VIEWABILITY

Retrieved on: 
Thursday, March 21, 2024
ADH, Trust, Accreditation, Google Ads, MRC, Mobile web, Media Rating Council, Integral Ad Science, IAS, Advertising

The full scope of the accreditation covers IAS's third party calculation and reporting of Google ADH-MP measurement data from the Google Ads, Display & Video 360, and YouTube Reserve services.

Key Points: 
  • The full scope of the accreditation covers IAS's third party calculation and reporting of Google ADH-MP measurement data from the Google Ads, Display & Video 360, and YouTube Reserve services.
  • Calculation and reporting is with respect to Google YouTube Video Impressions, Viewable Video Impressions and related Viewability metrics across Desktop, Mobile Web, and Mobile In-App environments.
  • Advertising formats are inclusive of Google's YouTube skippable in-stream ads, non-skippable in-stream ads, standard in-stream, YouTube in-stream select, and bumper ads.
  • "We congratulate IAS for achieving accreditation for their third-party calculation and reporting of YouTube video impression delivery and viewability based on audited ADH data," said George Ivie, CEO and Executive Director, MRC.

Allied Digestive Health and Provation Sign Agreement for Enhanced Patient Care

Retrieved on: 
Thursday, January 18, 2024
Technology, Surgery, Medical Devices, Hospitals, Health Technology, Software, Managed Care, Health, Data Management, Patient, ASC, FTV, Life, OBS, Documentation, Software as a service, ADH, Nursing, Fortive, GI, Digestate, Physician

For ADH, the mission to deliver top-tier patient care while running operations efficiently is a top priority.

Key Points: 
  • For ADH, the mission to deliver top-tier patient care while running operations efficiently is a top priority.
  • ADH's decision to incorporate both Provation Apex Procedure Documentation and Patient Charting solutions demonstrates leadership in the clinical care space.
  • With Provation Apex, physicians and nurses have the power to document patient visits and procedures seamlessly, on any internet-enabled device.
  • ADH and Provation have a shared vision of the future of GI patient care through enhanced workflow automation and procedure documentation.

Patient Engagement Solutions Market Worth $41.8 Billion | MarketsandMarkets

Retrieved on: 
Friday, December 15, 2023
Cloud, Acquisition, Conditional sentence, Athenahealth, Investment, Patient, Oracle Corporation, Growth, Hospital, Diabetes, RWE, Market development, Cardiovascular disease, Health, Roe, MEA, MEDITECH, EHR, Research, Tablet, Obesity, McKesson Corporation, ADH, Epic Systems, Francisco Partners, Software, Pulse, Medical device, Nursing, Health care, Pharmaceutical industry, IQVIA, Telehealth, Merck, Humana, Merative

In 2023, the software segment is estimated to account for the largest share of the patient engagement solutions market.

Key Points: 
  • In 2023, the software segment is estimated to account for the largest share of the patient engagement solutions market.
  • In terms of delivery mode, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes.
  • Patient Engagement Solutions Market Dynamics:
    Key Market Players of Patient Engagement Solutions Industry:
    Prominent players in patient engagement solutions market are McKesson Corporation (US), Veradigm (US), Oracle Corporation (US), Merative (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), Luma Health Inc. (US), WellStack(US), Vivify Health (US), Medhost (US), MEDISYSINC (US), and  Patient point LLC (US).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.

Patient Engagement Solutions Market Worth $41.8 Billion | MarketsandMarkets

Retrieved on: 
Friday, December 15, 2023
Cloud, Acquisition, Conditional sentence, Athenahealth, Investment, Patient, Oracle Corporation, Growth, Hospital, Diabetes, RWE, Market development, Cardiovascular disease, Health, Roe, MEA, MEDITECH, EHR, Research, Tablet, Obesity, McKesson Corporation, ADH, Epic Systems, Francisco Partners, Software, Pulse, Medical device, Nursing, Health care, Pharmaceutical industry, IQVIA, Telehealth, Merck, Humana, Merative

In 2023, the software segment is estimated to account for the largest share of the patient engagement solutions market.

Key Points: 
  • In 2023, the software segment is estimated to account for the largest share of the patient engagement solutions market.
  • In terms of delivery mode, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes.
  • Patient Engagement Solutions Market Dynamics:
    Key Market Players of Patient Engagement Solutions Industry:
    Prominent players in patient engagement solutions market are McKesson Corporation (US), Veradigm (US), Oracle Corporation (US), Merative (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), Luma Health Inc. (US), WellStack(US), Vivify Health (US), Medhost (US), MEDISYSINC (US), and  Patient point LLC (US).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.

Allied Digestive Health Becomes Suki Center of Excellence in Gastroenterology

Retrieved on: 
Thursday, December 7, 2023
Health, EHR, Organization, Practitioner, Suki, Patient, Electronic health record, Anesthesiology, Documentation, ADH, Gastroenterology, Partnership, SVP, AI, Physician, Marie Cassidy, Center of excellence, Medical device, Nursing, Pharmaceutical industry

REDWOOD CITY, Calif., Dec. 7, 2023 /PRNewswire/ -- Suki, a leading provider of voice artificial intelligence-powered healthcare solutions, today announces a partnership with Allied Digestive Health (ADH), the third-largest gastroenterology organization in the country. Comprised of over 200 gastroenterologists, pathologists, anesthesiologists, nurse practitioners, and physician assistants, ADH will become a Center of Excellence for Suki to help set best practices on how AI can most effectively be used in the gastroenterology field. This partnership serves as a significant milestone in achieving the companies' shared goals of providing clinicians with cutting-edge technologies to improve care and drive efficacy that lowers organizational costs.

Key Points: 
  • Comprised of over 200 gastroenterologists, pathologists, anesthesiologists, nurse practitioners, and physician assistants, ADH will become a Center of Excellence for Suki to help set best practices on how AI can most effectively be used in the gastroenterology field.
  • ADH has also invested significantly in building a best-in-class digital patient experience that includes online appointment scheduling, billing, and more.
  • "I have been impressed with the comprehensiveness of the notes generated by Suki," said Dr. Arthur Talansky, gastroenterologist with ADH.
  • "We are thrilled to partner with Allied Digestive Health, the AI leader in gastroenterology, to elevate both the patient and provider experience.

AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023

Retrieved on: 
Wednesday, October 11, 2023
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Clinical Trials, Infection, AN2, Kidney, PK, IDSA, Infectious Diseases Society of America, Alcohol dehydrogenase, Impact, Therapy, NTM, Poster, Mycobacteroides abscessus, MAC, Genotype, ADH, Conference, Tablet, Patient, Pharmaceutical industry, Pharmacokinetics, Safety

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced two oral presentations and three poster presentations at the Infectious Disease Society of America (IDSA) IDWeek 2023 Conference from October 11-15, 2023 in Boston, Massachusetts.

Key Points: 
  • AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced two oral presentations and three poster presentations at the Infectious Disease Society of America (IDSA) IDWeek 2023 Conference from October 11-15, 2023 in Boston, Massachusetts.
  • AN2 Therapeutics is currently enrolling patients in the Phase 3 part of its pivotal Phase 2/3 clinical trial evaluating once-daily, oral epetraborole for treatment-refractory Mycobacterium avium complex (MAC) lung disease.
  • “We are excited to showcase our latest data at IDWeek 2023.
  • These results highlight epetraborole’s potent nonclinical activity against MAC isolates, as well as M. abscessus, another difficult-to-treat NTM pathogen.

ATELIER Playa Mujeres Wins the "2023 Mexico's Leading Conference Hotel" Award at the World Travel Awards

Retrieved on: 
Saturday, September 2, 2023
Canada, Travel, Tourism, ADH, Handicraft, Convention center, Conference, Hotel

CANCÚN, Mexico, Sept. 2, 2023 /PRNewswire-PRWeb/ -- ATELIER Playa Mujeres "All Suites Luxury Resort," operated by ADH - ATELIER de Hoteles, the Mexican hotel chain renowned for its innovative concept of Handcrafted Hospitality®, has announced that it has once again received the "Mexico's Leading Conference Hotel" award presented annually by the World Travel Awards organization.

Key Points: 
  • ATELIER Playa Mujeres announced that it has once again received the "Mexico's Leading Conference Hotel" award presented by the World Travel Awards organization.
  • CANCÚN, Mexico, Sept. 2, 2023 /PRNewswire-PRWeb/ -- ATELIER Playa Mujeres "All Suites Luxury Resort," operated by ADH - ATELIER de Hoteles , the Mexican hotel chain renowned for its innovative concept of Handcrafted Hospitality®, has announced that it has once again received the "Mexico's Leading Conference Hotel" award presented annually by the World Travel Awards organization.
  • We're immensely proud to receive the 'Mexico's Leading Conference Hotel' award for the third year in a row.
  • ATELIER Playa Mujeres continues solidifying its position as a paragon of excellence in the all-inclusive ultra-luxury hotel market.

Iterative Health Partners with Allied Digestive Health for Clinical Trial Optimization

Retrieved on: 
Friday, May 5, 2023
Medical Devices, Health, Health Technology, Clinical Trials, Research, Science, Partnership, Drug development, Therapy, Gastroenterology, IBD, Business, Multimedia, Ulcerative colitis, Inflammatory bowel disease, Clinical trial, Patient, Physician, ADH, Medicine, AI, GI, Pharmaceutical industry, Hospital

Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Allied Digestive Health (ADH), a leading gastroenterology practice, to bring Clinical Trial Optimization to ADH’s research centers across New Jersey and New York to aid in the recruitment of patients for inflammatory bowel disease clinical trials.

Key Points: 
  • Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Allied Digestive Health (ADH), a leading gastroenterology practice, to bring Clinical Trial Optimization to ADH’s research centers across New Jersey and New York to aid in the recruitment of patients for inflammatory bowel disease clinical trials.
  • “With Iterative Health’s Clinical Trial Optimization technology, our recruitment efforts will reach more individuals, be more streamlined, and help accelerate the drug development process.
  • “Iterative Health’s technology supports our vision to elevate the standard of care in gastroenterology across the nation,” says Sap Sinha, Chief Operating Officer of Allied Digestive Health.
  • Our partnership lays the foundation for continued innovation in GI as Iterative Health strengthens its comprehensive suite of AI enabled tools to bring precision medicine to the GI practice.”
    To learn more about Iterative Health and Clinical Trial Optimization, visit the company’s website: https://iterative.health/

AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

Retrieved on: 
Wednesday, March 29, 2023
Biotechnology, FDA, Health, General Health, Public Relations, Investor Relations, Pharmaceutical, Communications, Research, Infectious Diseases, Science, Clinical Trials, Infectious Diseases Society of America, Use, Interest, AN2, Civil service commission, Alcohol dehydrogenase, National Institute of Allergy and Infectious Diseases, Infection, Medicines and Healthcare products Regulatory Agency, Clinical research associate, Clinical trial, Trial of the century, Pharmacokinetics, Global health, IDSA, ID, MAC, NTM, Nontuberculous mycobacteria, Patient, Investment, Administration, PMDA, ADH, European, Diagnosis, Entrepreneurship, Mortality, Research and development, Therapy, R, Conference, European Commission, Safety, Pharmaceutical industry, Video game, Fine chemical, Cryptocurrency

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended December 31, 2022.
  • R&D expenses for the fourth quarter of 2022 were $8.7 million, compared to $5.8 million for the same period last year.
  • General and administrative expenses for the fourth quarter of 2022 were $3.7 million, compared to $1.8 million for the same period last year.
  • Interest and other income, net for the fourth quarter of 2022 was $0.6 million, compared to $0.05 million for the fourth quarter of 2021.

Nammos to Expand into Hospitality Sphere with Launch of Nammos Hotels & Resorts

Retrieved on: 
Monday, March 27, 2023
Culture, NHR, History, Renewable energy, Investment, ADH, Golden Sands, Amusement park, Hotel, Mediterranean Sea, Nammo, Resort

LONDON, March 27, 2023 /PRNewswire/ -- We are delighted to announce the launch of Nammos Hotels & Resorts. Adding another layer to Nammos World, the new hospitality brand is a result of ADMO - a joint venture between Alpha Dhabi and Monterock International. Encapsulating the effortless exclusivity and service Nammos and its iconic beachside restaurants have become synonymous with over the past 20 years, the hotels and resorts will provide a holistic hospitality experience befitting of the international jet-set. Opening its doors on the golden sands of Psarou beach this summer, Nammos Hotel Mykonos will mark the brand's first property, with resorts in the Maldives and Abu Dhabi on the horizon. 

Key Points: 
  • Adding another layer to Nammos World , the new hospitality brand is a result of ADMO - a joint venture between Alpha Dhabi and Monterock International .
  • Catering to the most sophisticated of travellers and stylish sybarites, Nammos Hotels & Resorts will provide an unrivalled and genuine hospitality experience that mirrors elements of the existing Nammos offerings, whilst evoking a true sense of laid-back luxury.
  • At Nammos Hotels & Resorts the guest experience will take centre stage through world-class entertainment, signature gastronomy and unfaltering attention to detail.
  • Adding another layer to Nammos World's existing lifestyle offerings, Nammos Hotels and Resorts (NHR) is a new hospitality brand from ADMO - a joint venture between Alpha Dhabi and Monterock International .